We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Preclinical Hybrid Imaging Platform

By Biotechdaily staff writers
Posted on 17 Apr 2006
A novel preclinical imaging platform enables researchers to improve their research efforts and drug discovery applications.

Available as a modular or integrated system, the Inveon, developed by Siemens Medical Solutions (Erlangen, Germany), can be utilized in any combination of Siemens' preclinical hybrid imaging systems and sophisticated applications for improved research. More...
The system was recently presented at the Academy of Molecular Imaging (AMI) meeting, held in Orlando, FL,USA, on March 25-29, 2006.
"Siemens preclinical solutions are driving medical research from the laboratory to the clinic,” stated Michael Reitermann, president, Molecular Imaging Division, Siemens Medical Solutions. "Inveon offers limitless solutions and the highest performance and versatility available to address research needs from academic and translational research, to drug discovery and development.”

Molecular medicine combines sophisticated imaging with molecular biomarkers to enable the identification of disease pathways and evaluate the actions of novel therapies. As more disease-specific biomarkers are developed, researchers may be able to increase the speed at which drugs come to market. Inveon can help facilitate basic research as well as the drug development process, allowing researchers to identify specific biologic processes, track the efficacy of compounds, and evaluate the effects of disease progression over time.

The system enables unified control of positron emission tomography (PET), single-photon emission computed tomography (SPECT), and computed tomography (CT) data acquisition, and an extremely high PET resolution and sensitivity. Inveon features advanced multi-pinhole SPECT collimators for improved sensitivity and spatial resolution; new PET and SPECT acquisition and processing technology; and a unique PET transmission method for faster and more accurate attenuation correction.




Related Links:
Siemens Medical Solutions

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
POC Immunoassay Analyzer
Procise DX
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.